Compare Estee Lauder Companies Inc (EL) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs Nomura Holdings Inc — how do they compare? Estee Lauder Companies Inc trades at $98.05 (market cap $34.17B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Estee Lauder Companies Inc is the larger of the two by market cap, and Nomura Holdings Inc pays the higher dividend (3.4%). Which is the better fit depends on your goals — on Pluang, investors hold Estee Lauder Companies Inc for 122 Days and Nomura Holdings Inc for 55 Days on average.
| EL | NMR | |
|---|---|---|
Market Cap | $34.17B | $27.55B |
Volume | 3,921,497 | 782,470 |
Sector | Consumer Staples | Financials |
52-Week High | $119.61 | $10.86 |
52-Week Low | $67.23 | $6.73 |
Typical Hold Time | 122 Days | 55 Days |
Enterprise Value | $39.92B | $38.54T |
Dividend Yield | 1.48% | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EL trades at $94.32, down 0.14% on the day, with a neutral technical signal. The stock has beaten earnings estimates for the last three quarters, though annual revenue declined to $14.33B in 2025 with a net loss of $1.13B. Analyst consensus is a Buy with a $103.00 price target, and recent news highlights strategic partnerships in AI and leadership appointments aimed at strengthening brand strategy.
The outlook is cautiously optimistic, supported by earnings beats and positive analyst sentiment, but risks include sustained profitability challenges, high debt levels, and competitive pressures. Upside potential exists if margin improvements and strategic initiatives translate to earnings growth, yet investors must monitor execution on turnaround efforts.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
